WO2019237812A1 - Adipose tissue digestive juice and method for rapidly obtaining stromal vascular fraction cells - Google Patents

Adipose tissue digestive juice and method for rapidly obtaining stromal vascular fraction cells Download PDF

Info

Publication number
WO2019237812A1
WO2019237812A1 PCT/CN2019/082387 CN2019082387W WO2019237812A1 WO 2019237812 A1 WO2019237812 A1 WO 2019237812A1 CN 2019082387 W CN2019082387 W CN 2019082387W WO 2019237812 A1 WO2019237812 A1 WO 2019237812A1
Authority
WO
WIPO (PCT)
Prior art keywords
digestion
adipose tissue
cells
digestive juice
collagenase
Prior art date
Application number
PCT/CN2019/082387
Other languages
French (fr)
Chinese (zh)
Inventor
王一飞
陈海佳
葛啸虎
黄幸
王小燕
Original Assignee
广州赛莱拉干细胞科技股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 广州赛莱拉干细胞科技股份有限公司 filed Critical 广州赛莱拉干细胞科技股份有限公司
Publication of WO2019237812A1 publication Critical patent/WO2019237812A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662Stem cells
    • C12N5/0667Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0645Macrophages, e.g. Kuepfer cells in the liver; Monocytes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0653Adipocytes; Adipose tissue
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0656Adult fibroblasts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/069Vascular Endothelial cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00Methods for the dissociation of cells, e.g. specific use of enzymes

Definitions

  • the invention relates to the technical field of cell separation, in particular to adipose tissue digestive juice and a method for quickly obtaining stromal vascular component cells.
  • MSCs Mesenchymal stem cells
  • Stromal vascular component cells are adipose-derived regenerative cells found in particles aspirated from fat, and more than 30% of them are adipose-derived stem cells. SVF is obtained after adipose tissue is digested, filtered, and centrifuged to remove mature adipocytes. In 2001, Zuk first discovered that SVF contains a variety of cellular components, including MSCs, endothelial precursor cells, macrophages, smooth muscle cells and other components, and can induce differentiation into adipocytes, osteoblasts, chondrocytes, etc.
  • SVF can promote the healing of difficult-to-heal wounds by differentiating into vascular endothelial cells, secreting pro-angiogenesis and anti-apoptotic growth factors.
  • Adding SVF in the process of transplanting fat found that its effect is very considerable: it can improve the survival rate of adipocytes, and it can also significantly improve the texture of the skin.
  • the conventional method for obtaining SVF is to use a certain concentration of type I collagenase for constant temperature shock digestion.
  • the conventional isolation method uses type I collagenase digestion with a final concentration of 0.25% to obtain SVF in about 40 minutes.
  • Each milliliter of fat can be digested by collagenase to obtain SVF of 1.0-2.5 ⁇ 10 5 , and the activity rate is 70% -85%. It can be seen that it takes a long time to obtain cells with stromal vascular components, and the viability is low. Therefore, there is a need to provide a digestion method with shorter digestion time and higher cell viability.
  • the present invention provides adipose tissue digestive fluid and a method for quickly obtaining stromal vascular component cells.
  • This method can quickly obtain stromal vascular component cells, shortening the time to 15-20 minutes, and at the same time, the cell viability has been significantly improved.
  • the invention provides adipose tissue digestive juice, which is composed of type I collagenase, HEPES buffer solution and DMEM / F12 medium.
  • the traditional method of digestion did not pay attention to the change of the system pH during the digestion process.
  • This study found that the type I collagenase in the conventional method is not in the optimal pH environment, so the time to obtain SVF is longer.
  • the method of the invention adds a buffer system of HEPES buffer solution to the digestion system, so that the digestion system can be stably maintained between pH 6.8 and 8.2, and the type I collagenase activity is optimized to achieve complete digestion in a short time.
  • the SVF obtained by the traditional digestion scheme takes 40 minutes, and the digestion scheme added with additional buffering components according to the present invention can obtain high quality and quantity of SVF within 15-20 minutes.
  • the amount of each component in the digestive juice is:
  • Type I collagenase 0.1 wt% to 0.3 wt%;
  • HEPES buffer 1 ⁇ 30mM
  • DMEM / F12 medium To complement.
  • the amount of each component in the digestive juice is:
  • Type I collagenase 0.25% by weight
  • HEPES buffer 5 ⁇ 25mM
  • DMEM / F12 medium To complement.
  • the amount of each component in the digestive juice is:
  • Type I collagenase 0.25% by weight
  • HEPES buffer 10 ⁇ 25mM
  • DMEM / F12 medium To complement.
  • the amount of each component in the digestive juice is:
  • Type I collagenase 0.25% by weight
  • HEPES buffer 20mM
  • DMEM / F12 medium To complement.
  • the amount of each component in the digestive juice is:
  • Type I collagenase 0.25% by weight
  • HEPES buffer 25mM
  • DMEM / F12 medium To complement.
  • the invention also provides a method for quickly obtaining stromal vascular component cells, including the following steps:
  • the digestive fluid provided by the present invention is used to digest adipose tissue to obtain stromal vascular component cells; the digestive fluid is composed of type I collagenase, HEPES buffer solution and DMEM / F12 medium.
  • the digestion temperature is 36 to 38 ° C.
  • the temperature of digestion is 37 ° C.
  • the rotation speed of the digestion is 100 to 200 rpm.
  • the rotation speed of the digestion is 150 rpm.
  • the digestion time is 15 to 25 minutes.
  • the digestion time is 20 minutes.
  • the steps of centrifugation to terminate the digestion and washing are further included after the digestion.
  • the invention provides adipose tissue digestive fluid and a method for quickly obtaining stromal vascular component cells.
  • the adipose tissue digestive fluid is composed of type I collagenase, HEPES buffer and DMEM / F12 medium.
  • the invention has one of the following advantages:
  • the adipose tissue digestive fluid provided by the present invention can stably maintain the digestive system between pH 6.8 and 8.2, optimize the type I collagenase activity, and achieve complete digestion in a short time.
  • the SVF obtained by the traditional digestion scheme takes 40 minutes, and the digestive juice of the present invention can be used to digest adipose tissue, and a high quality and quantity of SVF can be obtained in 15-20 minutes.
  • the test results show that the SVF activity rate obtained by digesting adipose tissue with the digestive juice of the present invention is above 85%.
  • the digestive juice formula of the invention is simple and suitable for industrial production.
  • Figure 1 shows the expression of surface markers on each cell
  • Figure 2 shows the effect of adipogenic staining of cells.
  • the invention discloses an adipose tissue digestive fluid and a method for quickly obtaining stromal vascular component cells.
  • Adipose tissue (adipose tissue issue): mainly composed of a large number of clusters of fat cells, agglomerated fat cells are separated by a thin layer of loose connective tissue into small leaflets. Reticulated fibers in adipose tissue are well developed. Yellow (white) adipose tissue is yellow (white in some mammals), which is commonly referred to as adipose tissue. It consists of a large number of single-vesicle adipocytes. The adipocytes are round or polygonal. There is a large lipid droplet in the center of the cell, and the cytoplasm is a thin layer. It is located around the periphery of the cell and surrounds the lipid droplet.
  • the nucleus On HE slices, the lipid droplets were dissolved into a large vacuole.
  • the nucleus is oblate and is pushed to one side of the cell by lipid droplets. It is crescent-shaped with part of the cytoplasm.
  • the yellow adipose tissue is mainly distributed in the subcutaneous tissue, omentum, and mesentery. In adult men, it usually accounts for about 10% to 20% of body weight, and women tend to have more.
  • the largest "energy bank" in the body It has the functions of storing fat, maintaining body temperature and participating in fat metabolism. It is involved in energy metabolism and has the functions of generating heat, maintaining body temperature, buffering protection and supporting filling.
  • Brown adipose tissue is brown, which is characterized by rich capillaries in the tissue. Fat cells are scattered with many small lipid droplets. The mitochondria are large and rich. The nucleus is round and located in the center of the cell. Such adipocytes are called polyfoam adipocytes
  • Stromal vascular component cells Adipose tissue is mainly composed of adipocytes, ASCs, vascular endothelial cells, pericytes, fibroblasts, macrophages and extracellular matrix. Each cubic centimeter volume of adipose tissue includes 1 ⁇ 10 6 adipocytes, 1 ⁇ 10 6 ASCs, 1 ⁇ 10 6 vascular endothelial cells, and (1 ⁇ 2) ⁇ 10 6 other cells (such as blood source Cells) provide a rich source of stromal stem cells for research and applications in tissue engineering and regenerative medicine.
  • SVF stromatal vascular component cells
  • Collagenase specifically hydrolyzes the three-dimensional helical structure of natural collagen under physiological pH and temperature conditions without damaging other proteins and tissues.
  • the chemical nature of collagenase is a protein, so it is very sensitive to temperature, pH, and various factors that cause protein denaturation, and it is very susceptible to external conditions to change its conformation and properties.
  • Collagenase I is used for the isolation of epithelial, lung, fat and adrenal tissue cells. It is used to digest the connecting part of the tissue to make it a single cell. It is used for the isolation of mammalian cells. Its optimum pH is 6.3 ⁇ 8.8.
  • DMEM / F12 medium F12 medium is rich in ingredients and contains various trace elements. It is combined with DMEM at a ratio of 1: 1 and is called DMEM / F12 medium (DME / F12medium). It is used as a basis for developing serum-free formula to utilize F12. Contains richer ingredients and DMEM contains higher concentrations of nutrients as advantages. The medium is suitable for mammalian cell culture under conditions of low serum content.
  • HEPES buffer non-toxic to cells. It is a hydrogen ion buffer that can control a constant pH range for a longer period of time.
  • adipose tissue digestive fluid provided by the present invention and the reagents or instruments used in the method for quickly obtaining stromal vascular component cells can be purchased from the market.
  • Collagen type I 0.25%
  • HEPES buffer 5mM
  • the above raw materials are all sterile.
  • Collagen type I 0.25%
  • HEPES buffer 10mM
  • the above raw materials are all sterile.
  • Collagen type I 0.25%
  • HEPES buffer 15mM
  • the above raw materials are all sterile.
  • Collagen type I 0.25%
  • HEPES buffer 20mM
  • the above raw materials are all sterile.
  • Collagen type I 0.25%
  • HEPES buffer 25mM
  • the above raw materials are all sterile.
  • the digestive formula of this comparative example is:
  • Collagen type I 0.25%
  • the above raw materials are all sterile.
  • the adipose tissue was washed until no red blood cells were visible to the naked eye, and digestion was performed using the above digestion solution, digestion was performed at 37 ° C, and shaking at 150 rpm for 20 min.
  • Test example 2 SVF culture test
  • Test Example 3 Immune phenotype analysis of adipose stem cells after SVF culture
  • SVF third-generation cells digested from the digestive juices of Examples 1-5 and Comparative Examples 1-3 were taken, washed three times after digestion, and made into a cell suspension. Antibodies were added, and CD73, CD90, CD105, and CD11b, CD19, CD34, CD45, HLA-DR expression. The test results are shown in Table 3 and Figure 1:
  • the above test results indicate that the cells are adipose-derived mesenchymal stem cells.
  • SVF third-generation cells obtained by digestion with the digestion liquid of Examples 1-5 and Comparative Examples 1-3 were taken and seeded at a concentration of 2.5 ⁇ 10 4 cells in a 24-well plate containing DMEM / F12 + 20% FBS medium to the cells.
  • change to a culture solution containing 1 nmol / L dexamethasone, 10 mg / L insulin, 0.5 mmol / L 3-isobutyl-1-methylxanthine, 100 ⁇ mol / L indomethacin Change the solution twice, fix with paraformaldehyde 3 weeks later, and stain with oil red O.
  • the adipogenic effect is shown in Figure 2. Visible stained lipid droplets prove that the cells have adipogenic differentiation ability.

Abstract

A adipose tissue digestive juice and a method for rapidly obtaining stromal vascular fraction (SVF) cells are provided. The adipose tissue digestive juice is composed of a type I collagenase, a HEPES buffer solution and a DMEM/F12 culture medium, and the adipose tissue can be digested to obtain SVF.

Description

脂肪组织消化液和快速获得基质血管成分细胞的方法Adipose tissue digestive fluid and method for quickly obtaining stromal vascular component cells
本申请要求于2018年06月15日提交中国专利局、申请号为201810618076.9、发明名称为“脂肪组织消化液和快速获得基质血管成分细胞的方法”的中国专利申请的优先权,其全部内容通过引用结合在本申请中。This application claims the priority of a Chinese patent application filed on June 15, 2018 with the Chinese Patent Office, application number 201810618076.9, and the invention name "Adipose Tissue Digestive Fluid and Method for Rapidly Obtaining Matrix Vessel Component Cells", the entire content of which is approved Citations are incorporated in this application.
技术领域Technical field
本发明涉及细胞分离技术领域,特别涉及脂肪组织消化液和快速获得基质血管成分细胞的方法。The invention relates to the technical field of cell separation, in particular to adipose tissue digestive juice and a method for quickly obtaining stromal vascular component cells.
背景技术Background technique
难愈性创面在外科疾病中是常见病,具有病程长、并发症多、对外观影响大的特点,近年来有逐年增多的趋势,成为严重影响患者生活质量的因素。如何促进难愈性创面愈合是一直被探索的问题,然而到目前为止仍没有一种理想的方法。间充质干细胞(MSCs)被首次发现存在于骨髓中,它是一种具有多向分化潜能的细胞,具有促进组织再生的潜能。MSCs能通过促进局部组织的血管形成及组织再生从而加速创面的愈合。但是由于骨髓中的MSCs含量较低而且提取困难而限制了骨髓来源的MSCs在临床中的应用。近期的研究发现脂肪组织中也存在着大量的MSCs,而脂肪组织具有来源丰富、获取对组织损伤小的特点。而且脂肪中的干细胞含量、细胞的扩张及增殖能力都明显优于骨髓组织。Refractory wounds are common in surgical diseases. They have the characteristics of long course, many complications, and great influence on appearance. In recent years, they have been increasing year by year, and have become a factor that seriously affects the quality of life of patients. How to promote the healing of refractory wounds has been an explored problem, but so far there is no ideal method. Mesenchymal stem cells (MSCs) were found in the bone marrow for the first time. They are multipotent cells with the potential to promote tissue regeneration. MSCs can accelerate wound healing by promoting angiogenesis and tissue regeneration in local tissues. However, the bone marrow-derived MSCs are low in content and difficult to extract, which limits the clinical application of bone marrow-derived MSCs. Recent studies have found that there are also a large number of MSCs in adipose tissue, and adipose tissue has the characteristics of abundant sources and little damage to tissues. And the content of stem cells in fat, cell expansion and proliferation ability are significantly better than bone marrow tissue.
基质血管成分细胞(SVF)是从脂肪抽吸的颗粒中发现的含有脂肪源性的再生细胞,其中有30%以上为脂肪源性干细胞。SVF是脂肪组织通过消化、过滤、离心去除成熟的脂肪细胞后得到的。2001年Zuk首次发现SVF包含多种细胞成分,包括MSCs、内皮前体细胞、巨噬细胞、平滑肌细胞等成分,而且可以诱导分化为成脂肪细胞、成骨细胞、成软骨细胞等。Stromal vascular component cells (SVF) are adipose-derived regenerative cells found in particles aspirated from fat, and more than 30% of them are adipose-derived stem cells. SVF is obtained after adipose tissue is digested, filtered, and centrifuged to remove mature adipocytes. In 2001, Zuk first discovered that SVF contains a variety of cellular components, including MSCs, endothelial precursor cells, macrophages, smooth muscle cells and other components, and can induce differentiation into adipocytes, osteoblasts, chondrocytes, etc.
近期的研究认为SVF可以通过分化成血管内皮细胞、分泌促血管形成及抗凋亡的生长因子等多方面来促进难愈性创面的愈合。在移植脂肪的过程中添加SVF,发现它的作用非常可观:能提升脂肪细胞的成活率,而且它还能明显改善皮肤质地,对移植部位有很好的修复作用,同时缓解敏感。Recent research suggests that SVF can promote the healing of difficult-to-heal wounds by differentiating into vascular endothelial cells, secreting pro-angiogenesis and anti-apoptotic growth factors. Adding SVF in the process of transplanting fat found that its effect is very considerable: it can improve the survival rate of adipocytes, and it can also significantly improve the texture of the skin.
目前获得SVF的常规方法是采用一定浓度的I型胶原酶恒温震荡消化。常规的分离方法采用终浓度0.25%的I型胶原酶消化需要约40min得到SVF。 每毫升脂肪通过胶原酶的消化可获得1.0~2.5×10 5的SVF,活率在70%~85%。可见常规获取基质血管成分细胞的时间较长,且活率较低。因此,需要提供一种消化时间更短、细胞活率更高的消化方法。 At present, the conventional method for obtaining SVF is to use a certain concentration of type I collagenase for constant temperature shock digestion. The conventional isolation method uses type I collagenase digestion with a final concentration of 0.25% to obtain SVF in about 40 minutes. Each milliliter of fat can be digested by collagenase to obtain SVF of 1.0-2.5 × 10 5 , and the activity rate is 70% -85%. It can be seen that it takes a long time to obtain cells with stromal vascular components, and the viability is low. Therefore, there is a need to provide a digestion method with shorter digestion time and higher cell viability.
发明内容Summary of the Invention
有鉴于此,本发明提供了脂肪组织消化液和快速获得基质血管成分细胞的方法。该方法可快速获得基质血管成分细胞,将时间缩短至15~20min,同时细胞活率也得到了显著提高。In view of this, the present invention provides adipose tissue digestive fluid and a method for quickly obtaining stromal vascular component cells. This method can quickly obtain stromal vascular component cells, shortening the time to 15-20 minutes, and at the same time, the cell viability has been significantly improved.
为了实现上述发明目的,本发明提供以下技术方案:In order to achieve the above-mentioned object, the present invention provides the following technical solutions:
本发明提供了一种脂肪组织消化液,由I型胶原酶、HEPES缓冲液和DMEM/F12培养基组成。The invention provides adipose tissue digestive juice, which is composed of type I collagenase, HEPES buffer solution and DMEM / F12 medium.
传统的消化方法中并未关注消化过程中体系pH的变动,本研究发现常规方法中I型胶原酶并不是处于最佳pH环境,所以得到SVF时长较长。本发明方法在消化体系中添加HEPES缓冲液的缓冲体系,使消化体系能够稳定维持在pH6.8~8.2之间,使I型胶原酶活性达到最佳,从而实现短时间消化完全。传统消化方案得到的SVF耗时40min,而本发明添加有额外缓冲成分的消化方案可以在15~20min内获得高质量和数量的SVF。The traditional method of digestion did not pay attention to the change of the system pH during the digestion process. This study found that the type I collagenase in the conventional method is not in the optimal pH environment, so the time to obtain SVF is longer. The method of the invention adds a buffer system of HEPES buffer solution to the digestion system, so that the digestion system can be stably maintained between pH 6.8 and 8.2, and the type I collagenase activity is optimized to achieve complete digestion in a short time. The SVF obtained by the traditional digestion scheme takes 40 minutes, and the digestion scheme added with additional buffering components according to the present invention can obtain high quality and quantity of SVF within 15-20 minutes.
作为优选,消化液中各组分的用量为:Preferably, the amount of each component in the digestive juice is:
I型胶原酶:          0.1wt%~0.3wt%;Type I collagenase: 0.1 wt% to 0.3 wt%;
HEPES缓冲液:        1~30mM;HEPES buffer: 1 ~ 30mM;
DMEM/F12培养基:     补足。DMEM / F12 medium: To complement.
优选地,消化液中各组分的用量为:Preferably, the amount of each component in the digestive juice is:
I型胶原酶:          0.25wt%;Type I collagenase: 0.25% by weight;
HEPES缓冲液:        5~25mM;HEPES buffer: 5 ~ 25mM;
DMEM/F12培养基:     补足。DMEM / F12 medium: To complement.
优选地,消化液中各组分的用量为:Preferably, the amount of each component in the digestive juice is:
I型胶原酶:          0.25wt%;Type I collagenase: 0.25% by weight;
HEPES缓冲液:        10~25mM;HEPES buffer: 10 ~ 25mM;
DMEM/F12培养基:     补足。DMEM / F12 medium: To complement.
更优选地,消化液中各组分的用量为:More preferably, the amount of each component in the digestive juice is:
I型胶原酶:          0.25wt%;Type I collagenase: 0.25% by weight;
HEPES缓冲液:        20mM;HEPES buffer: 20mM;
DMEM/F12培养基:     补足。DMEM / F12 medium: To complement.
更优选地,消化液中各组分的用量为:More preferably, the amount of each component in the digestive juice is:
I型胶原酶:          0.25wt%;Type I collagenase: 0.25% by weight;
HEPES缓冲液:        25mM;HEPES buffer: 25mM;
DMEM/F12培养基:     补足。DMEM / F12 medium: To complement.
本发明还提供了一种快速获得基质血管成分细胞的方法,包括如下步骤:The invention also provides a method for quickly obtaining stromal vascular component cells, including the following steps:
采用本发明提供的消化液消化脂肪组织,获得基质血管成分细胞;该消化液,由I型胶原酶、HEPES缓冲液和DMEM/F12培养基组成。The digestive fluid provided by the present invention is used to digest adipose tissue to obtain stromal vascular component cells; the digestive fluid is composed of type I collagenase, HEPES buffer solution and DMEM / F12 medium.
作为优选,消化的温度为36~38℃。Preferably, the digestion temperature is 36 to 38 ° C.
在本发明提供的实施例中,消化的温度为37℃。In the embodiment provided by the present invention, the temperature of digestion is 37 ° C.
作为优选,消化的转速为100~200rpm。Preferably, the rotation speed of the digestion is 100 to 200 rpm.
在本发明提供的实施例中,消化的转速为150rpm。In the embodiment provided by the present invention, the rotation speed of the digestion is 150 rpm.
作为优选,消化的时间为15~25min。Preferably, the digestion time is 15 to 25 minutes.
在本发明提供的实施例中,消化的时间为20min。In the embodiment provided by the present invention, the digestion time is 20 minutes.
在本发明提供的实施例中,消化后还包括离心终止消化、清洗的步骤。In the embodiment provided by the present invention, the steps of centrifugation to terminate the digestion and washing are further included after the digestion.
本发明提供了脂肪组织消化液和快速获得基质血管成分细胞的方法。该脂肪组织消化液由I型胶原酶、HEPES缓冲液和DMEM/F12培养基组成。本发明具有如下优势之一:The invention provides adipose tissue digestive fluid and a method for quickly obtaining stromal vascular component cells. The adipose tissue digestive fluid is composed of type I collagenase, HEPES buffer and DMEM / F12 medium. The invention has one of the following advantages:
1、本发明提供的脂肪组织消化液可使消化体系能够稳定维持在pH6.8~8.2之间,使I型胶原酶活性达到最佳,从而实现短时间消化完全。传统消化方案得到的SVF耗时40min,而采用本发明消化液对脂肪组织进行消化,可以在15~20min内获得高质量和数量的SVF。试验结果显示,采用本发明消化液对脂肪组织进行消化获得的SVF活率在85%以上。1. The adipose tissue digestive fluid provided by the present invention can stably maintain the digestive system between pH 6.8 and 8.2, optimize the type I collagenase activity, and achieve complete digestion in a short time. The SVF obtained by the traditional digestion scheme takes 40 minutes, and the digestive juice of the present invention can be used to digest adipose tissue, and a high quality and quantity of SVF can be obtained in 15-20 minutes. The test results show that the SVF activity rate obtained by digesting adipose tissue with the digestive juice of the present invention is above 85%.
2、本发明消化液配方简单,适合工业化生产。2. The digestive juice formula of the invention is simple and suitable for industrial production.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
图1示各细胞表面标记表达情况;Figure 1 shows the expression of surface markers on each cell;
图2示细胞成脂染色效果。Figure 2 shows the effect of adipogenic staining of cells.
具体实施方式detailed description
本发明公开了脂肪组织消化液和快速获得基质血管成分细胞的方法,本领域技术人员可以借鉴本文内容,适当改进工艺参数实现。特别需要指出的是,所有类似的替换和改动对本领域技术人员来说是显而易见的,它们都被视为包括在本发明。本发明的方法及应用已经通过较佳实施例进行了描述,相关人员明显能在不脱离本发明内容、精神和范围内对本文所述的方法和应用进行改动或适当变更与组合,来实现和应用本发明技术。The invention discloses an adipose tissue digestive fluid and a method for quickly obtaining stromal vascular component cells. Those skilled in the art can learn from the content of this article and appropriately improve the process parameters for implementation. In particular, it should be noted that all similar replacements and modifications will be apparent to those skilled in the art, and they are all considered to be included in the present invention. The method and application of the present invention have been described through the preferred embodiments. It is obvious that relevant persons can modify or appropriately modify and combine the methods and applications described herein without departing from the content, spirit, and scope of the present invention. Apply the technology of the present invention.
术语解释:Explanation of terms:
脂肪组织(adipose tissue):主要由大量群集的脂肪细胞构成,聚集成团的脂肪细胞由薄层疏松结缔组织分隔成小叶。脂肪组织中的网状纤维很发达。黄(白)色脂肪组织呈黄色(在某些哺乳动物呈白色),即通常所说的脂肪组织。它由大量单泡脂肪细胞集聚而成,脂肪细胞呈圆形或多边形,细胞中央有一大脂滴,胞质呈薄层,位于细胞周缘,包绕脂滴。在HE切片上,脂滴被溶解成一大空泡。胞核扁圆形,被脂滴推挤到细胞一侧,连同部分胞质呈新月形。黄色脂肪组织主要分布在皮下组织、网膜和肠系膜等处,在成年男子一般约占体重的10%~20%,女人往往更多一些。体内最大的“能源库”。具有贮存脂肪、保持体温和参与脂肪代谢的功能。参与能量代谢,并具有产生热量、维持体温、缓冲保护和支持填充等作用。棕色脂肪组织呈棕色,其特点是组织中有丰富的毛细血管,脂肪细胞内散在许多小脂滴,线粒体大而丰富,核圆形,位于细胞中央。这种脂肪细胞称为多泡脂肪细胞。Adipose tissue (adipose tissue issue): mainly composed of a large number of clusters of fat cells, agglomerated fat cells are separated by a thin layer of loose connective tissue into small leaflets. Reticulated fibers in adipose tissue are well developed. Yellow (white) adipose tissue is yellow (white in some mammals), which is commonly referred to as adipose tissue. It consists of a large number of single-vesicle adipocytes. The adipocytes are round or polygonal. There is a large lipid droplet in the center of the cell, and the cytoplasm is a thin layer. It is located around the periphery of the cell and surrounds the lipid droplet. On HE slices, the lipid droplets were dissolved into a large vacuole. The nucleus is oblate and is pushed to one side of the cell by lipid droplets. It is crescent-shaped with part of the cytoplasm. The yellow adipose tissue is mainly distributed in the subcutaneous tissue, omentum, and mesentery. In adult men, it usually accounts for about 10% to 20% of body weight, and women tend to have more. The largest "energy bank" in the body. It has the functions of storing fat, maintaining body temperature and participating in fat metabolism. It is involved in energy metabolism and has the functions of generating heat, maintaining body temperature, buffering protection and supporting filling. Brown adipose tissue is brown, which is characterized by rich capillaries in the tissue. Fat cells are scattered with many small lipid droplets. The mitochondria are large and rich. The nucleus is round and located in the center of the cell. Such adipocytes are called polyfoam adipocytes.
基质血管成分细胞(SVF):脂肪组织主要由脂肪细胞、ASCs、血管内皮细胞、周细胞、成纤维细胞、巨嚼细胞和细胞外基质组成。每立方厘米体积的脂肪组织中,包括有1×10 6个脂肪细胞、1×10 6个ASCs、1×10 6个血管内皮细胞和(1~2)×10 6个其他细胞(如血液来源的细胞)自体脂肪组织为组织工程和再生医学的研究及应用提供了丰富的基质干细胞来源。研究者现已通过酶消化的方法,从腹壁整形术或吸脂术废弃的脂肪组织中分离提取基质血管成分细胞(Stromal Vascular Fraction Cells,SVF)。SVF是一个脂肪来源干细胞与其他细胞成分相混杂的群体,经过体外贴壁培养后可获得较纯的脂肪来源基质/干细胞(adipose-derived stromal/stem cells,ASCs)。 Stromal vascular component cells (SVF): Adipose tissue is mainly composed of adipocytes, ASCs, vascular endothelial cells, pericytes, fibroblasts, macrophages and extracellular matrix. Each cubic centimeter volume of adipose tissue includes 1 × 10 6 adipocytes, 1 × 10 6 ASCs, 1 × 10 6 vascular endothelial cells, and (1 ~ 2) × 10 6 other cells (such as blood source Cells) provide a rich source of stromal stem cells for research and applications in tissue engineering and regenerative medicine. Researchers have now used enzyme digestion to separate and extract stromatal vascular component cells (SVF) from adipose tissue discarded by abdominal wall plastic surgery or liposuction. SVF is a population of adipose-derived stem cells mixed with other cell components. After adherent culture in vitro, pure adipose-derived stromal / stem cells (ASCs) can be obtained.
磷酸盐缓冲液:PBS,全称Phosphate Buffered Saline。在医学词汇中表示磷酸盐缓冲液,用于分子克隆及细胞培养,pH=7.4,与人体血液等渗,主要成分为磷酸二氢钾、磷酸氢二钠、氯化钠以及氯化钾。Phosphate buffer: PBS, full name Phosphate Buffered Saline. In medical terms, it means phosphate buffer solution, used for molecular cloning and cell culture, pH = 7.4, isotonic with human blood, the main components are potassium dihydrogen phosphate, disodium hydrogen phosphate, sodium chloride and potassium chloride.
胶原酶:在生理PH和温度条件下特异性地水解天然胶原蛋白的三维螺旋结构,而不损伤其它蛋白质和组织。胶原酶的化学本质是一种蛋白质,因此,这对温度、pH和导致蛋白质变性的各种因素均非常敏感,极易受到外界条件的影响而改变其本身的构象和性质。胶原酶Ⅰ用于上皮、肺,脂肪和肾上腺组织细胞的分离。用于消化组织中连接部分使其成为单个细胞,用于哺乳动细胞的分离,其最适pH为6.3~8.8。Collagenase: specifically hydrolyzes the three-dimensional helical structure of natural collagen under physiological pH and temperature conditions without damaging other proteins and tissues. The chemical nature of collagenase is a protein, so it is very sensitive to temperature, pH, and various factors that cause protein denaturation, and it is very susceptible to external conditions to change its conformation and properties. Collagenase I is used for the isolation of epithelial, lung, fat and adrenal tissue cells. It is used to digest the connecting part of the tissue to make it a single cell. It is used for the isolation of mammalian cells. Its optimum pH is 6.3 ~ 8.8.
DMEM/F12培养基:F12培养基成分丰富,含有多种微量元素,和DMEM以1:1结合,称为DMEM/F12培养基(DME/F12medium),作为开发无血清配方的基础,以利用F12含有较丰富的成分和DMEM含有较高浓度的营养成分为优点。该培养基适用于血清含量较低条件下哺乳动物细胞培养。DMEM / F12 medium: F12 medium is rich in ingredients and contains various trace elements. It is combined with DMEM at a ratio of 1: 1 and is called DMEM / F12 medium (DME / F12medium). It is used as a basis for developing serum-free formula to utilize F12. Contains richer ingredients and DMEM contains higher concentrations of nutrients as advantages. The medium is suitable for mammalian cell culture under conditions of low serum content.
HEPES缓冲液:对细胞无毒性作用。它是一种氢离子缓冲剂,能较长时间控制恒定的pH范围。HEPES buffer: non-toxic to cells. It is a hydrogen ion buffer that can control a constant pH range for a longer period of time.
以下实施例中%表示质量百分含量。In the following examples, "%" represents mass percentage content.
本发明提供的脂肪组织消化液和快速获得基质血管成分细胞的方法中所用试剂或仪器均可由市场购得。The adipose tissue digestive fluid provided by the present invention and the reagents or instruments used in the method for quickly obtaining stromal vascular component cells can be purchased from the market.
下面结合实施例,进一步阐述本发明:The following further describes the present invention in combination with the embodiments:
实施例1Example 1
1、本实施例消化配方为:1. The digestion formula of this embodiment is:
I型胶原酶:0.25%;Collagen type I: 0.25%;
HEPES缓冲液:5mM;HEPES buffer: 5mM;
DMEM/F12培养基:补足。DMEM / F12 medium: make up.
上述原料皆为无菌。The above raw materials are all sterile.
2、消化方法:2. Digestion method:
清洗脂肪组织直至无肉眼可见红细胞,剪碎至30立方毫米左右,采用上述消化液进行消化,消化20min,37℃,150rpm震荡。Wash the adipose tissue until no red blood cells are visible to the naked eye, cut it to about 30 cubic millimeters, and digest with the digestive juice, digestion for 20 min, 37 ° C, and shaking at 150 rpm.
实施例2Example 2
1、本实施例消化配方为:1. The digestion formula of this embodiment is:
I型胶原酶:0.25%;Collagen type I: 0.25%;
HEPES缓冲液:10mM;HEPES buffer: 10mM;
DMEM/F12培养基:补足。DMEM / F12 medium: make up.
上述原料皆为无菌。The above raw materials are all sterile.
2、消化方法:2. Digestion method:
清洗脂肪组织直至无肉眼可见红细胞,剪碎至30立方毫米左右,采用上述消化液进行消化,消化20min,37℃,150rpm震荡。Wash the adipose tissue until no red blood cells are visible to the naked eye, cut it to about 30 cubic millimeters, and digest with the digestive juice, digestion for 20 min, 37 ° C, and shaking at 150 rpm.
实施例3Example 3
1、本实施例消化配方为:1. The digestion formula of this embodiment is:
I型胶原酶:0.25%;Collagen type I: 0.25%;
HEPES缓冲液:15mM;HEPES buffer: 15mM;
DMEM/F12培养基:补足。DMEM / F12 medium: make up.
上述原料皆为无菌。The above raw materials are all sterile.
2、消化方法:2. Digestion method:
清洗脂肪组织直至无肉眼可见红细胞剪碎至30立方毫米左右,采用上述消化液进行消化,消化20min,37℃,150rpm震荡。Wash the adipose tissue until no visible red blood cells are shredded to about 30 cubic millimeters. Digestion is performed using the above digestion solution. Digestion is performed for 20 minutes at 37 ° C with shaking at 150 rpm.
实施例4Example 4
1、本实施例消化配方为:1. The digestion formula of this embodiment is:
I型胶原酶:0.25%;Collagen type I: 0.25%;
HEPES缓冲液:20mM;HEPES buffer: 20mM;
DMEM/F12培养基:补足。DMEM / F12 medium: make up.
上述原料皆为无菌。The above raw materials are all sterile.
2、消化方法:2. Digestion method:
清洗脂肪组织直至无肉眼可见红细胞,剪碎至30立方毫米左右,采用上述消化液进行消化,消化20min,37℃,150rpm震荡。Wash the adipose tissue until no red blood cells are visible to the naked eye, cut it to about 30 cubic millimeters, and digest with the above digestion solution, digest for 20 min, shake at 37 ° C, 150 rpm.
实施例5Example 5
1、本实施例消化配方为:1. The digestion formula of this embodiment is:
I型胶原酶:0.25%;Collagen type I: 0.25%;
HEPES缓冲液:25mM;HEPES buffer: 25mM;
DMEM/F12培养基:补足。DMEM / F12 medium: make up.
上述原料皆为无菌。The above raw materials are all sterile.
2、消化方法:2. Digestion method:
清洗脂肪组织直至无肉眼可见红细胞,剪碎至30立方毫米左右,采用上述消化液进行消化,消化20min,37℃,150rpm震荡。Wash the adipose tissue until no red blood cells are visible to the naked eye, cut it to about 30 cubic millimeters, and digest with the above digestion solution, digest for 20 min, shake at 37 ° C, 150 rpm.
对比例1Comparative Example 1
传统的消化方法:终浓度0.25%I型胶原酶(含0.25%I型胶原酶的PBS溶液)消化40min,37℃,150rpm震荡。Traditional digestion method: final concentration of 0.25% type I collagenase (PBS solution containing 0.25% type I collagenase) is digested for 40 min, shaking at 37 ° C, 150 rpm.
对比例2Comparative Example 2
传统的消化方法:终浓度0.25%I型胶原酶(含0.25%I型胶原酶的PBS溶液)消化20min,37℃,150rpm震荡。Traditional digestion method: Final concentration of 0.25% type I collagenase (PBS solution containing 0.25% type I collagenase) is digested for 20 min, shaking at 37 ° C, 150 rpm.
对比例3Comparative Example 3
本对比例消化配方为:The digestive formula of this comparative example is:
I型胶原酶:0.25%;Collagen type I: 0.25%;
DMEM/F12培养基:补足。DMEM / F12 medium: make up.
上述原料皆为无菌。The above raw materials are all sterile.
2、消化方法:2. Digestion method:
清洗脂肪组织直至无肉眼可见红细胞,采用上述消化液进行消化,消化20min,37℃,150rpm震荡。The adipose tissue was washed until no red blood cells were visible to the naked eye, and digestion was performed using the above digestion solution, digestion was performed at 37 ° C, and shaking at 150 rpm for 20 min.
试验例1 消化试验Test example 1 digestion test
采集脂肪组织(均经过志愿者授权同意,年龄20~30岁,无传染性疾病), 生理盐水清洗后用终浓度0.25%的上述实施例1-5和对比例1-3配方在37℃、150rpm震荡下消化20min或40min,后离心终止消化,仅留底部细胞,生理盐水清洗后得到SVF,检测SVF活率和数量。试验结果见表1:Collect adipose tissue (both authorized and consented by volunteers, aged 20-30 years old, no infectious diseases), after washing with normal saline, use a final concentration of 0.25% of the above Examples 1-5 and Comparative Examples 1-3 at 37 ° C, Digestion was performed with shaking at 150rpm for 20min or 40min, and the digestion was terminated by centrifugation, leaving only the bottom cells, and SVF was obtained after washing with physiological saline, and the SVF viability and quantity were detected. The test results are shown in Table 1:
表1 SVF活率和数量Table 1 SVF activity rate and quantity
Figure PCTCN2019082387-appb-000001
Figure PCTCN2019082387-appb-000001
可见:在SVF获取量上本发明实施例1-5配方明显优于对比例1-3配方;在SVF活率上,实施例1-5配方也明显优于对比例1-3配方。It can be seen that the formula of Examples 1-5 of the present invention is significantly better than the formula of Comparative Examples 1-3 in the amount of SVF obtained; the formula of Examples 1-5 is also significantly better than the formula of Comparative Examples 1-3 in terms of SVF activity.
试验例2 SVF培养试验Test example 2 SVF culture test
试验例1中各组消化得到的SVF,各取5.0×10 5SVF接种在一个10cm皿,加入10mL DMEM/F12+10%FBS培养基,于5%CO 2、37℃培养箱培养,每2天换液(于第3、5天时换液),每天观察细胞汇合度,记录汇合度变化趋势。试验结果见表2: SVF obtained by digestion of each group in Test Example 1, each 5.0 × 10 5 SVF was inoculated in a 10cm dish, 10mL DMEM / F12 + 10% FBS medium was added, and cultured in a 5% CO 2 , 37 ° C incubator, every 2 Change the liquid every day (change the liquid on the 3rd and 5th days), observe the confluence of the cells every day, and record the change trend of the confluence. The test results are shown in Table 2:
表2 SVF汇合度变化趋势Table 2 SVF convergence degree change trend
Figure PCTCN2019082387-appb-000002
Figure PCTCN2019082387-appb-000002
Figure PCTCN2019082387-appb-000003
Figure PCTCN2019082387-appb-000003
可见,本发明实施例1-5配方获得的SVF的增殖能力明显优于对比例1-3配方获得的SVF。It can be seen that the proliferation ability of the SVF obtained from the formulations of Examples 1-5 of the present invention is significantly better than the SVF obtained from the formulations of Comparative Examples 1-3.
试验例3 SVF培养后脂肪干细胞免疫表型分析Test Example 3 Immune phenotype analysis of adipose stem cells after SVF culture
取实施例1-5和对比例1-3消化液消化得到的SVF第3代细胞,消化后清洗3次,制成细胞悬液,加入抗体,流式细胞仪检测分析CD73、CD90、CD105、CD11b、CD19、CD34、CD45、HLA-DR的表达情况。试验结果见表3、图1:SVF third-generation cells digested from the digestive juices of Examples 1-5 and Comparative Examples 1-3 were taken, washed three times after digestion, and made into a cell suspension. Antibodies were added, and CD73, CD90, CD105, and CD11b, CD19, CD34, CD45, HLA-DR expression. The test results are shown in Table 3 and Figure 1:
表3 细胞表面标记表达情况Table 3 Expression of cell surface markers
Figure PCTCN2019082387-appb-000004
Figure PCTCN2019082387-appb-000004
上述检测结果表明该细胞是脂肪间充质干细胞。The above test results indicate that the cells are adipose-derived mesenchymal stem cells.
试验例4 体外向脂肪细胞诱导分化检测Test Example 4 In vitro and In vivo Differential Detection of Adipocytes
取实施例1-5和对比例1-3消化液消化得到的SVF第3代细胞,按2.5×10 4细胞浓度接种于含有DMEM/F12+20%FBS培养基的24孔板中,至细胞80%融合时,更换为含有1nmol/L地塞米松、10mg/L胰岛素、0.5mmol/L 3-异丁基-1-甲基黄嘌呤、100μmol/L吲哚美辛的培养液,每周换液2次,3周后用多聚甲醛 固定,油红O染色。成脂效果如图2所示,可见清晰被染色脂滴,证明细胞具有成脂分化能力。 SVF third-generation cells obtained by digestion with the digestion liquid of Examples 1-5 and Comparative Examples 1-3 were taken and seeded at a concentration of 2.5 × 10 4 cells in a 24-well plate containing DMEM / F12 + 20% FBS medium to the cells. At 80% confluence, change to a culture solution containing 1 nmol / L dexamethasone, 10 mg / L insulin, 0.5 mmol / L 3-isobutyl-1-methylxanthine, 100 μmol / L indomethacin Change the solution twice, fix with paraformaldehyde 3 weeks later, and stain with oil red O. The adipogenic effect is shown in Figure 2. Visible stained lipid droplets prove that the cells have adipogenic differentiation ability.
以上所述仅是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。The above is only a preferred embodiment of the present invention. It should be noted that, for those of ordinary skill in the art, without departing from the principle of the present invention, a number of improvements and retouches can be made. These improvements and retouches also It should be regarded as the protection scope of the present invention.

Claims (10)

  1. 一种脂肪组织消化液,其特征在于,由I型胶原酶、HEPES缓冲液和DMEM/F12培养基组成。An adipose tissue digestive fluid, characterized in that it consists of type I collagenase, HEPES buffer and DMEM / F12 medium.
  2. 根据权利要求1所述的消化液,其特征在于,所述消化液中各组分的用量为:The digestive juice according to claim 1, wherein the amount of each component in the digestive juice is:
    I型胶原酶:            0.1wt%~0.3wt%;Type I collagenase: 0.1wt% ~ 0.3wt%;
    HEPES缓冲液:          1~30mM;HEPES buffer solution: 1 ~ 30mM;
    DMEM/F12培养基:       补足。DMEM / F12 medium: To complement.
  3. 根据权利要求1所述的消化液,其特征在于,所述消化液中各组分的用量为:The digestive juice according to claim 1, wherein the amount of each component in the digestive juice is:
    I型胶原酶:            0.25wt%;Type I collagenase: 0.25% by weight;
    HEPES缓冲液:          5~25mM;HEPES buffer: 5 ~ 25mM;
    DMEM/F12培养基:       补足。DMEM / F12 medium: To complement.
  4. 根据权利要求1所述的消化液,其特征在于,所述消化液中各组分的用量为:The digestive juice according to claim 1, wherein the amount of each component in the digestive juice is:
    I型胶原酶:            0.25wt%;Type I collagenase: 0.25% by weight;
    HEPES缓冲液:          10~25mM;HEPES buffer: 10 ~ 25mM;
    DMEM/F12培养基:       补足。DMEM / F12 medium: To complement.
  5. 根据权利要求1至4中任一项所述的消化液,其特征在于,所述消化液中各组分的用量为:The digestive juice according to any one of claims 1 to 4, wherein the amount of each component in the digestive juice is:
    I型胶原酶:            0.25wt%;Type I collagenase: 0.25% by weight;
    HEPES缓冲液:          20mM;HEPES buffer: 20mM;
    DMEM/F12培养基:       补足。DMEM / F12 medium: To complement.
  6. 一种快速获得基质血管成分细胞的方法,其特征在于,包括如下步骤:A method for quickly obtaining stromal vascular component cells, comprising the following steps:
    采用如权利要求1至5中任一项所述消化液消化脂肪组织,获得基质血管成分细胞。Adipose tissue is digested with the digestive juice according to any one of claims 1 to 5 to obtain stromal vascular component cells.
  7. 根据权利要求6所述的方法,其特征在于,所述消化的温度为36~38℃。The method according to claim 6, wherein the temperature of the digestion is 36-38 ° C.
  8. 根据权利要求6所述的方法,其特征在于,所述消化的转速为 100~200rpm。The method according to claim 6, wherein the rotation speed of the digestion is 100-200 rpm.
  9. 根据权利要求6所述的方法,其特征在于,所述消化的时间为15~25min。The method according to claim 6, wherein the digestion time is 15-25 minutes.
  10. 根据权利要求6至9中任一项所述的方法,其特征在于,所述消化后还包括离心终止消化、清洗的步骤。The method according to any one of claims 6 to 9, characterized in that the digestion further comprises the steps of centrifugation to terminate the digestion and washing.
PCT/CN2019/082387 2018-06-15 2019-04-12 Adipose tissue digestive juice and method for rapidly obtaining stromal vascular fraction cells WO2019237812A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201810618076.9A CN108841785A (en) 2018-06-15 2018-06-15 Adipose tissue digestive juice and the method for being quickly obtained stromal vascular fraction cell
CN201810618076.9 2018-06-15

Publications (1)

Publication Number Publication Date
WO2019237812A1 true WO2019237812A1 (en) 2019-12-19

Family

ID=64203001

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2019/082387 WO2019237812A1 (en) 2018-06-15 2019-04-12 Adipose tissue digestive juice and method for rapidly obtaining stromal vascular fraction cells

Country Status (2)

Country Link
CN (1) CN108841785A (en)
WO (1) WO2019237812A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108841785A (en) * 2018-06-15 2018-11-20 广州赛莱拉干细胞科技股份有限公司 Adipose tissue digestive juice and the method for being quickly obtained stromal vascular fraction cell
CN112226406A (en) * 2020-10-19 2021-01-15 中国医学科学院北京协和医院 Preparation method of human perivascular adipose tissue single cell suspension

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108841785A (en) * 2018-06-15 2018-11-20 广州赛莱拉干细胞科技股份有限公司 Adipose tissue digestive juice and the method for being quickly obtained stromal vascular fraction cell

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1443846A (en) * 2002-03-07 2003-09-24 中国医学科学院基础医学研究所 Clone of rat testis specific gene rt SH3p13 and biological function of its protein
US20030236212A1 (en) * 2002-04-10 2003-12-25 Jean-Louis Dasseux Functionalized long chain derivatives as acyl coenzyme-A mimics, compositions thereof, and methods of cholesterol management and related uses
US20070027543A1 (en) * 2005-08-01 2007-02-01 Gimble Jeffrey M Use of adipose tissue-derived stromal cells in spinal fusion
CN106236745B (en) * 2016-07-21 2019-04-12 中国科学院微生物研究所 The purposes of aromatic series farnesyl class compound

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108841785A (en) * 2018-06-15 2018-11-20 广州赛莱拉干细胞科技股份有限公司 Adipose tissue digestive juice and the method for being quickly obtained stromal vascular fraction cell

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
TANG, SHENGQIU ET AL.: "Effects of pGhrelin on Caspase-3 Activity and Gene Expression of Porcine Predipocytes in Culture", PROGRESS IN BIIOCHEMISTRY AND BIOPHYSICS, vol. 36, no. 7, 31 December 2009 (2009-12-31), pages 897 - 903, XP055668785, DOI: 10.3724/SP.J.1206.2008.00714 *
XIN, LINGBIAO: "Transgenic SND1 Ameliorates HFD-Induced Hepatic Steatosis and Insulin Resistance", MEDICINE & PUBLIC HEALTH, CHINA DOCTORAL DISS., no. 2, 15 February 2017 (2017-02-15), pages 34, ISSN: 1674-022X *

Also Published As

Publication number Publication date
CN108841785A (en) 2018-11-20

Similar Documents

Publication Publication Date Title
CN106906182B (en) Serum-free medium for mesenchymal stem cells
ES2613930T3 (en) Procedure of culturing cells from adipose tissue and their applications
Xu et al. Umbilical cord-derived mesenchymal stem cells isolated by a novel explantation technique can differentiate into functional endothelial cells and promote revascularization
CN102367435B (en) Preparation of human platelet-rich plasma and application of same in isolation and culture of human mesenchymal stem cells
CN106754674A (en) Method and its application of amnion mesenchymal stem cell are prepared from Human plactnta amnion
CN1912109B (en) Structural method and application of tissue engineering adipose tissue
CN105238751A (en) Umbilical cord tissue mesenchymal stem cell isolated culture method
CN108184818B (en) Human placenta mesenchymal stem cell suspension protective agent
CN106359368A (en) Cell cryoprotectant and cryopreservation method
Pu et al. Compared to the amniotic membrane, Wharton’s jelly may be a more suitable source of mesenchymal stem cells for cardiovascular tissue engineering and clinical regeneration
CN102517251A (en) Mesenchymal stem cells, as well as preparation method and application thereof
CN111621476B (en) Serum-free culture medium for mesenchymal stem cells and preparation method thereof
CN106434557A (en) Method for preparing CD34 positive cells from umbilical cord mesenchymal stem cells
CN110438072A (en) The preparation method of fat mesenchymal stem cell
CN108795855A (en) A kind of serum free medium of mescenchymal stem cell
CN104651305A (en) Method for acquiring bioactive proteins by utilizing umbilical cord mesenchymal stem cells
CN107557331A (en) A kind of method for separating and cultivating human adipose-derived stem cell
Taha et al. Adipose-derived stem/progenitor cells from lipoaspirates: A comparison between the Lipivage200-5 liposuction system and the Body-Jet liposuction system
CN103087982A (en) Kit and method capable of quickly separating adipose tissue-derived stem cells
WO2019237812A1 (en) Adipose tissue digestive juice and method for rapidly obtaining stromal vascular fraction cells
CN102146359A (en) Method for extracting original mesenchymal stem cells from placenta and serum-free amplification
WO2006134951A1 (en) Long-term culture proliferation method for fat-derived stem cell
CN106417253A (en) Cryopreservation liquid and method for skeletal muscle stem cells
ES2764199T3 (en) Procedure to produce multipotent stem cells and progenitors
CN101760445B (en) Method for amplifying autologous bone marrow mesenchymal stem cells

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19818775

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 30/03/2021)

122 Ep: pct application non-entry in european phase

Ref document number: 19818775

Country of ref document: EP

Kind code of ref document: A1